We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Open Biosystems' Open Access RNAi Program Adopted by John's Hopkins University and University of Manitoba
News

Open Biosystems' Open Access RNAi Program Adopted by John's Hopkins University and University of Manitoba

Open Biosystems' Open Access RNAi Program Adopted by John's Hopkins University and University of Manitoba
News

Open Biosystems' Open Access RNAi Program Adopted by John's Hopkins University and University of Manitoba

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Open Biosystems' Open Access RNAi Program Adopted by John's Hopkins University and University of Manitoba"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Open Biosystems, Inc. has announced that leading research institutions across North America continue to adopt its Open Access RNAi Program.

Johns Hopkins University and University of Manitoba have recently purchased access to Open Biosystems shRNAmir and shRNA technologies for RNAi by joining the Open Access RNAi Program.

Participation in the Open Access Programs allows all research laboratories within an institution access to its choice of Open Biosystems' portfolio of genome-wide resources including RNAi. The Open Access Program supports Open Biosystems' vision of supporting basic and medical research and reinforces its commitment to expanding access to research reagents for the life sciences community.

"Open Biosystems' Open Access Programs for RNAi and genomic resources provides a unique consolidated toolkit for murine and human gene analysis to our faculty members for defining the function, distribution and therapeutic potentials of human gene products in health and disease said Sam Kung, Assistant Professor, Department of Immunology.

“Under the support of the Dean Strategic Research Fund, we have established the Biomedical. Functionality Resource at the Faculty of Medicine, University of Manitoba to promote university-wide gene discovery and validation in multiple human disease,” Kung added.

"The Open Access Programs from Open Biosystems were created to address the key needs of our academic customers. Allowing institution-wide sharing of genome-scale resources in an organized and technically supported manner continues our commitment to facilitate genome-scale analysis at the bench top of individual scientists," said Troy Moore, Chief Technical Officer of Open Biosystems.

Open Biosystems' portfolio of RNAi resources include shRNAmir lentiviral and retroviral libraries targeting the entire human and mouse genomes, the RNAi Consortium human and mouse lentiviral shRNA libraries as well as RNAi collections targeting Drosophila, C. elegans and Zebrafish. These RNAi resources facilitate gene analysis on a genome scale.

Participation in the Open Access RNAi program provides researchers the complete and flexible access to evolving RNAi technologies.

Advertisement